Sunday, June 20, 2010

DIA Conference Recap: Come join our discussion!

Advanced Clinical attended the DIA conference June 13-17th, 2010 in downtown DC at the Washington Convention Center. It was an awesome week. We were able to meet so many people, while networking, brainstorming, and discussing numerous topics surrounding the clinical and pharmaceutical industry.

Our team was able to sit in on and discuss many interesting presentations. The one presentation that really hit it for us was the session “Fiscally Responsible Protocol Development: Minimizing Potholes and Avoiding Sinkholes” hosted by Anna Hindle, Anne Cropp and Ken Getz. The session outlined:

a) The financial impact of protocol amendments including the hidden costs

b) Protocol amendments correlation with therapeutic areas and functional areas, e.g., data management, clinical operations, etc.

c) Triggers/causes of protocol amendments

d) Characteristics of protocols that generate lots of amendments, e.g., the more Investigator sites, the more amendments

e) Amendments that are avoidable and amendments that are not avoidable

f) Lessons learned and tips / techniques for circumventing / preventing the avoidable amendments

Some interesting facts about amendments we learned: 40% of amendments occur before the first patient is in, 631 hours/amendment approval, 484 hours/amendment to implement, and a minimum of $60K per amendment - $400K per amendment. We also learned that the key triggers of amendments were due to: standard of care changes, safety issues, and the need to deal with sub-populations.

Advanced Clinical had some additional thoughts on the amendment front upon reflecting on this presentation:

a) Would be good to determine the characteristics of a good amendment and a “bad amendment”

b) It’s important to perform the analysis of doing the amendment vs. not doing the amendment

c) Perhaps consider the following items to deal with amendments more efficiently:

  • Think about doing amendments in “release” schedules like people do in software development
  • Use tools that allow standard language document components – there are some good document management tools that have this functionality
  • Create guidelines for the organization to evaluate whether or not an amendment should be performed
  • Understand the causes of amendments in your organization. Gather data around amendments for therapeutic area; cause; sub-population; hours to design/gain approval for amendment; hours to implement amendment
  • Create an ecosystem of experts to review the protocol before finalizing it to avoid amendments. Put more time into the protocol up front to ensure completeness and consideration of key areas where changes could occur
  • Make the language more flexible in the protocol to avoid the amendment, e.g., put in “5-9 sites” instead of “7 sites”

On top of the presentations, the exhibitions were excellent. Our favorite was Oracle’s demonstration of their new Oracle Clinical product. We were able to talk with Oracle and their product roadmap as it relates to their EDC product, “RDC”. Also we were able to discuss Oracle Clinical’s “big picture architecture including IVRS, IWRS, EDC, Business intelligence as well as the anchor Oracle Clinical Product.

Were there any presentations or exhibitions you particularly enjoyed or thought was informational? What are some of your thoughts on the presentations given? Hanging questions? Comments? Please let us know! Come join our discussion and comment or write on our wall in our Blog or on our Facebook page. We’d love to hear your ideas and takeaways from the DIA Conference.

AC also had the opportunity to host OYA for a networking happy hour. It was a huge success! We were able to gather so many great people from the DIA Conference. There was a lot of relaxing, socializing and brainstorming for advancing discoveries. If you weren’t able to make it, please join our discussion for Advancing Discoveries on our Facebook page at www.facebook.com/AdvClinical

See www.advancedclinical.com

Wednesday, June 16, 2010

Men's Health and Cancer Awareness Week

With Father's Day coming up this Sunday, June 20, it also marks the week for men's health and cancer awareness. See our blog post on women's cancer awareness week.

Due to a lack of awareness, poor health education and culturally induced behavioral patterns in their work and personal lives, men’s health and well being are deteriorating rapidly. Statistics show that men live sicker and die younger than American women. Men’s Health Week is to bring awareness to the fact that men can do things to prevent suffering and even dying from many avoidable and treatable diseases. It is important for men to pay attention to their bodies and visit a doctor whenever suspicious symptoms arise. Annual physicals are recommended to ensure proper screenings are done. Early detection and treatment of disease is extremely important to maximize your health. To download a Blueprint For Men’s Heath – a publication that discusses the main health issues that men face today – click on this link here.

Best wishes to all Fathers this coming Sunday. To quote Congressman Bill Richardson (Congressional Record, H3905-H39906, May 24, 1994):

“Recognizing and preventing men’s health problems is not just a man’s issue. Because of its impact on wives, mothers, daughters, and sisters, men’s health is truly a family issue.”

Medicine is making new strides everyday to advance discoveries to ease symptoms, cure disease, and better the human situation. Enter our “how do you advance discoveries” contest and your company could win an iPad and get a mention in our press release.

See www.advancedclinical.com

Thursday, June 10, 2010

Advanced Clinical: The CRO with Experience

Advanced Clinical has advanced many discoveries and has experience in over 192 trials in many therapeutic areas across Phases 1 though 4. Over the years, we've worked together with pharmaceutical companies to enhance medicine in disciplines which include but are not limited to:

1. Analgesia
2. Anti-Infective
3. Antiviral
4. Cardiology
5. Endocrinology
6. Gastrointestinal*
7. Geriatrics
8. Gynecology*
9. Hematology
10. Infectious Disease
11. Infertility
12. Musculoskeletal
13. Neurology
14. Oncology
15. Urology
16. Ophthalmology
17. Renal
18. Respiratory
19. Rheumatology*
20. Women's Health

*Advanced Clinical has over 25 trials' experience in these indicated disciplines.

Of our 192 trials, a whopping 191 of them used Advanced Clinical's Data Management service. Our Data Management service is reliable, resilient, and depended on by the best pharmaceutical, biotech and medical device companies in the industry. Our technology platform utilizes state-of-the-art tools: Oracle Clinical, Electronic Data Capture (EDC), and IVRS and IWRS (Interactive Voice or Web Response Systems).

Advanced Clinical also adheres to CDISC and SDTM standards with integrity checks and trial monitoring reports. Advanced Clinical is compliant with ICH, the FDA (21 CFR part 11) and GCP.

Our Biostatistics team is among the best in the nation and we continue to add strength and capabilities to the team in strategic therapeutic areas.

Advanced Clinical is prepared to handle any size trial. Within our body of work, 15 percent had over 500 subjects; one of those trials had over 5,000. We've done trials within the US at one site, and globally over hundreds of sites. Whatever your trial needs are, we will develop a plan and do our part to partner in your development.


Advanced Clinical's leading practices help drive the speed, improve the quality, and ensure the highest probability of success at the lowest total cost of ownership. Some of the delivery assets we use are:

• Our approach to collaborate, innovate, and optimize. Advanced Clinical believes in working together in collaboration, innovation through the Industry Leading R&D Process, and maintaining a continuous learning approach to optimize trials.

• Resource Management Model. Advanced Clinical not only retains, but nurtures our consultants to keep the best ones loyal and available for our exciting projects.

• Team Integration. Advanced Clinical wants to make the client team and the Advanced Clinical team integrated into one.

• Risk Management. Advanced Clinical identifies, assesses, prioritizes, mitigates, and tracks risks to proactively avoid issues that might arise

• Continuous Learning. Continually improving the trial as it goes on will optimize its overall success.

• Ramping. Advanced Clinical onboards, trains, and adapts the team to the client's environment, culture, project and needs.

• Project Management with Supply / Demand Management. Advanced Clinical will ensure clients get the right team, at the right time, and with optimal productivity with collaborative project management.

Use a clinical research organization with experience and an approach to support your growth: Advanced Clinical.

Does this sound like a great way to advance discoveries? We think it is. Enter our “how do you advance discoveries” contest and your company could win an iPad and get a mention in our press release.

See www.advancedclinical.com

Thursday, June 3, 2010

How do you advance discoveries? EXTENDED THROUGH JULY!

Now, you have through July to enter to win an iPad and a mention in our winners press release!




Shorten clinical trials. Reduce risk. Reduce cost! We need YOUR ideas!

Eighty billion drugs are predicted to come off patent in the next three years. While some say this release of patents may save money for the healthcare system as a whole because generics will take the place of those coming off patent, there is no replacement for many drugs and there are patients that need these drugs. As a result, Pharmaceuticals and Biotech companies have two key imperatives:

  • "Advance discoveries", aka, reduce clinical trial timelines

  • Reduce the escalating costs and risks associated with drug development


A recent article in the Wall Street Journal "Clinical Trial Death Watch" (March 16th 2010) echoes these imperatives. The message from the Wall Street Journal article is: there is a resounding need for efficiency and effectiveness to accelerate clinical trials. Even the government is trying to help with the acceleration of clinical trials. One recent study focused on collaboration. There are, however, still many complex issues that create barriers to realizing these imperatives. See, Forbes (March 26th, 2010 "Research and Markets: Investigating Clinical Trial Costs").

Advanced Clinical wants to ask pharmaceutical, biotechnology, and medical device companies, “How do you advance discoveries?” What are the best practices you use to shorten clinical trials? How do you reduce risk and cost in drug development? Do you have a strong risk management approach, employee training, or metrics management? Advanced Clinical would like your ideas to create Industry Leading Trial Performance in clinical research.

Let us know how you advance discoveries here. If you win, your ideas will be part of our press release in July, and you will win an iPad!

For winning list announcement, you can follow Advanced Clinical on facebook or on one of our social networks:

Advanced Clinical Facebook Page
http://twitter.com/AdvClinical
http://youtube.com/AdvancedClinical
http://AdvancedClinical.blogspot.com
http://AdvancedClinical.wordpress.com

See www.advancedclinical.com